Phenylboronic acid is a more potent inhibitor than boric acid of key signaling networks involved in cancer cell migration

作者：McAuley Erin M; Bradke Tiffany A; Plopper George E^*

来源：Cell Adhesion and Migration, 2011, 5(5): 382-386.

DOI：10.4161/cam.5.5.18162

• boric acid
• phenylboronic acid
• migration
• prostate cancer
• natural compounds
• DU-145

Previous studies from our lab have shown that both boric (BA) and phenylboronic acid (PBA) inhibit the migration of prostate cancer cell lines, as well as non-tumorigenic prostate cells. Our results indicate that PBA is more potent than BA in targeting metastatic and proliferative properties of cancer cells. Here we focus on the impact of BA and PBA on Rho family of GTP-binding proteins and their downstream targets. Treatment with 1 mM PBA and BA decreases activities of RhoA, Rac1 and Cdc42 in DU-145 metastatic prostate cancer cells, but not in normal RWPE-1 prostate cells. Furthermore, ROCKII activity and phosphorylation of myosin light chain kinase decrease as a result of either PBA or BA treatment in DU-145 cells, suggesting these compounds target actomyosin-based contractility.

• 出版日期2011-10